#57: Incentivizing adherence with Drs Steve Driver and Don Hensrud
Patient adherence-as recently demonstrated in the MI FREE trial-is a notoriously complicated issue that is the focus of several ongoing research projects. Drs Steve Driver and Don Hensrud join the show to discuss their innovative trial presented at ACC (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - April 26, 2013 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts

Canagliflozin; PURE; low-glycemic and Mediterranean diets
(Source: Radio TheHeart.org)
Source: Radio TheHeart.org - April 26, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#29: What's different about heart disease in women?
After years of being omitted from clinical trials, research is finally taking strides to recognize the specificity of heart disease in women. Dr Sharon Mulvagh joins Dr Bernard Gersh to ask why wouldn't there be differences in heart disease between women (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - April 22, 2013 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts

#187: Beet this: More evidence of BP-lowering effects of dietary nitrate; amiodarone-cancer link reemerges in observational study; ACE inhibitor, beta-blocker may thwart cardiotoxicity from chemotherapy; will new FDA meeting on Avandia prompt withdrawal?
Beet this: More evidence of BP-lowering effects of dietary nitrate; amiodarone-cancer link reemerges in observational study; ACE inhibitor, beta-blocker may thwart cardiotoxicity from chemotherapy; will new FDA meeting on Avandia prompt withdrawal o (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - April 19, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#186: Prasugrel noninferior to ticagrelor, but both achieve poor platelet inhibition at two hours; REVIVEd in print: REVIVE levosimendan trials finally get peer-review validation; nonsystem issues prolong door-to-balloon times, up mortality in primary PCI
Prasugrel noninferior to ticagrelor, but both achieve poor platelet inhibition at two hours; REVIVEd in print: REVIVE levosimendan trials finally get peer-review validation; nonsystem issues prolong door-to-balloon times, up mortality in primary PCI (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - April 12, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#28: Cardiac device infections: From A to Z
Despite the ever shrinking size of devices and our greater technical expertise, there has been a disproportionate rise in the rate infections associated with cardiac devices. Drs Raul Espinosa and M Rizwan Sohail join Dr Charanjit (Chet) Rihal to discuss (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - April 8, 2013 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts

#185: Carvedilol superior to metoprolol in MADIT-CRT analysis; FDA approves new diabetes drug, canagliflozin, despite CV concerns; heart-smart diabetes drugs; more beaches, less bureaucracy, say burned out cardiologists
Carvedilol superior to metoprolol in MADIT-CRT analysis; FDA approves new diabetes drug, canagliflozin, despite CV concerns; heart-smart diabetes drugs; more beaches, less bureaucracy, say burned out cardiologists (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - April 5, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#184: Rivaroxaban gets ACS indication recommendation from European regulators; MitraClip narrowly passes major test with FDA advisory panel; new oral anticoagulants in secondary stroke prevention: Apples and oranges?; EMA recommends restricting cilostazol
Rivaroxaban gets ACS indication recommendation from European regulators; MitraClip narrowly passes major test with FDA advisory panel; new oral anticoagulants in secondary stroke prevention: Apples and oranges?; EMA recommends restricting cilostazol (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 28, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts